With a 45 year track record of serving the healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co Ltd has established itself as a reliable manufacturer and supplier of pharmaceutical products and a contract manufacturing partner to the pharmaceutical industry. At Cheng Yi pharmaceutical, we dedicate our operational efforts to manufacturing excellence, strict compliance with cGMP requirements, and customer satisfaction. Our API manufacturing facilities were first audited by TGA in 1998, and have since been regularly inspected and consistently approved by other world regulatory authorities. In particular, we are proud of the success in the first-ever global joint audit of our facilities by FDA, EMEA and TGA in 2010. Our business comprises development, manufacturing and supply of APIs, pharmaceutical intermediates and dosage form products. Headquartered on Dongtou Island of Zhejiang Province and with sales center in Shanghai, Cheng Yi Pharmaceutical employs 560 and operates 2 manufacturing sites with total site area of 225000 sq meters, total reactor capacity of 451 cubic meters and fermentation capacity of 300 MT, as well as 2 dosage form production lines.
CN
